Advanced Fetal Cair Unit - Assiut University
Asyut, Egypt
NCT Number: NCT03108040
Intrauterine growth restriction (IUGR) is one of the major contributors to perinatal mortality and morbidity and is characterized by complex hemodynamic changes involving placental and fetal arterial, cardiac and venous circulations .However, the temporal sequence of these modifications in relation to other hemodynamic changes of the fetal arterial and venous circulations is unknown.
The aim of this study was to evaluate cardiac function and other hemodynamic changes in a group of fetuses with IUGR and clinical impact on perinatal outcome .
Looking for future studies?
Notify Me18 year–40 year
Female
Observational
Asyut, Egypt
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 minutes
Ratio between isovolumetric time to ejection time
Time frame: 5 minutes
Aortic isthmus flow index = Ratio of (systolic velocity time integral+diastolic velocity time integral) / systolic velocity time integral
Time frame: 5 minutes
cerebroplacental ratio = Rtio middle cerebral artery pulsatility index / umbilical artery pulsatility index
Time frame: 5 minutes
Preload Index in inferior vena cava = ratio of peak systolic velocity in atrial contraction /peak systolic velocity ventricular systole
Assiut University
Other
Evaluation of Non Invasive Fetal Cardiac Functions and Fetal Arterial&Venous Doppler Study in Intrauterine Growth Restriction as Predictive Parameters of Perinatal Outcome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04876846
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Walnut Creek, California, United States
View Trial DetailsNCT06405984
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Norfolk, Virginia, United States
View Trial DetailsNCT03146507
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Asyut, Egypt
View Trial DetailsNCT02741284
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Electronic Fetal Monitoring
St Louis, Missouri, United States
View Trial Details